This report focuses on the global Small Molecule Targeted Cancer Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Small Molecule Targeted Cancer Therapy development in United States, Europe and China. In 2017, the global Small Molecule Targeted Cancer Therapy market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025. The key players covered in this study OncoGenex Pharmaceuticals, Inc. Cytokinetics Inc. Hospira Inc. GlaxoSmithKline plc Boehringer Ingelheim GmbH Bayer HealthCare AG Abbott Laboratories ... Market segment by Type, the product can be split into Monoclonal Antibodies Small Molecules Small Molecule Drug Conjugates Market segment by Application, split into Lymphoma Melanoma Multiple Myeloma Breast Cancer Prostate Cancer Other Cancers Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Small Molecule Targeted Cancer Therapy status, future forecast, growth opportunity, key market and key players. To present the Small Molecule Targeted Cancer Therapy development in United States, Europe and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions. In this study, the years considered to estimate the market size of Small Molecule Targeted Cancer Therapy are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Type (2013-2025) 1.4.2 Monoclonal Antibodies 1.4.3 Small Molecules 1.4.4 Small Molecule Drug Conjugates 1.5 Market by Application
